A time-in-motion study of oral ibandronate versus iv zoledronic acid for treatment of metastatic bone disease in breast cancer patients

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.6123 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 6123-6123 ◽

Author(s):

A. Wardley ◽

J.-J. Body ◽

M. Neary

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Download Full-text

PCN9 ATIME-IN-MOTION STUDY OF ORAL IBANDRONATE VERSUS IV ZOLEDRONIC ACID FOR THE TREATMENT OF METASTATIC BONE DISEASE IN BREAST CANCER PATIENTS IN THE UK

Value in Health ◽

10.1016/s1098-3015(10)65743-9 ◽

2004 ◽

Vol 7 (6) ◽

pp. 671-672

Author(s):

A Wardley ◽

JJ Body ◽

M Neary ◽

G Lewis

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Motion Study ◽

Download Full-text

Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy

Supportive Care in Cancer ◽

10.1007/s00520-005-0828-1 ◽

2005 ◽

Vol 13 (12) ◽

pp. 975-986 ◽

Author(s):

E. De Cock ◽

J. Hutton ◽

P. Canney ◽

J. J. Body ◽

P. Barrett-Lee ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Zoledronic Acid ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Breast Cancer Patients

Download Full-text

Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study

Journal of Medical Economics ◽

10.3111/13696991003640383 ◽

2010 ◽

Vol 13 (1) ◽

pp. 162-167 ◽

Author(s):

S. Houston ◽

R.J. Grieve ◽

T. Hickish ◽

F. Percival ◽

E. Hamilton

Keyword(s):

Breast Cancer ◽

Renal Function ◽

Zoledronic Acid ◽

Cancer Patients ◽

Resource Use ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Interventional Study ◽

Ibandronic Acid

Download Full-text

P78. NHS resource use and capacity planning in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2008.03.111 ◽

2008 ◽

Vol 34 ◽

pp. 84-85

Author(s):

Robert Grieve ◽

Kate Peperell ◽

Elizabeth Hamilton

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Cancer Patients ◽

Resource Use ◽

Bone Disease ◽

Capacity Planning ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Ibandronic Acid

Download Full-text

Abstract P1-13-02: Ibandronate Shows Marked Pain Relief and a Favorable Renal Safety Profile — Final Results of a Large-Scale Non Interventional Study in Breast Cancer Patients with Metastatic Bone Disease

10.1158/0008-5472.sabcs10-p1-13-02 ◽

2010 ◽

Author(s):

M Schmidt ◽

T Hesse ◽

C Lerchenmueller ◽

IJ Diel

Keyword(s):

Breast Cancer ◽

Pain Relief ◽

Cancer Patients ◽

Bone Disease ◽

Safety Profile ◽

Large Scale ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Interventional Study ◽

Download Full-text

Ibandronate relieves pain and improves quality of life in breast cancer patients with metastatic bone disease: Phase III data

Bone ◽

10.1016/j.bone.2006.01.015 ◽

2006 ◽

Vol 38 (3) ◽

pp. 69-70

Author(s):

J.J. Body ◽

B. Bergström

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Phase Iii ◽

Breast Cancer Patients

Download Full-text

430 POSTER Efficacy of ibandronate for the prevention of skeletal-related events in breast cancer patients with metastatic bone disease

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80728-1 ◽

2005 ◽

Vol 3 (2) ◽

pp. 121 ◽

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Skeletal Related Events

Download Full-text

Renal Safety of Intravenous Ibandronic Acid in Breast Cancer Patients with Metastatic Bone Disease

Clinical Drug Investigation ◽

10.2165/00044011-200323110-00003 ◽

2003 ◽

Vol 23 (11) ◽

pp. 707-716 ◽

Author(s):

Nina V Lyubimova ◽

Nikolay E Kushlinsky ◽

Michail R Lichinitser ◽

Karl Schlosser

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Ibandronic Acid ◽

Download Full-text

Major issues in the treatment of metastatic bone disease: renal safety and maintained bone pain effectiveness of ibandronate in breast cancer patients in clinical practice; interim results of a non interventional study in Germany.

10.1158/0008-5472.sabcs-1159 ◽

2009 ◽

Author(s):

M Schmidt ◽

J Seraphin ◽

B Luhn ◽

U Soeling

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Cancer Patients ◽

Bone Disease ◽

Bone Pain ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Interventional Study ◽

Download Full-text

Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate

European Journal of Cancer ◽

10.1016/s0959-8049(99)80703-5 ◽

1999 ◽

Vol 35 ◽

pp. S83 ◽

Author(s):

I.J. Diel ◽

M.R. Lichinitser ◽

J.J. Body ◽

K. Schlosser ◽

J. Moecks ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Survival Time ◽

Cancer Patients ◽

Bone Disease ◽

Bone Pain ◽

Metastatic Bone Disease ◽

Breast Cancer Patients

Download Full-text